Corticosterone regulates pERK1/2 map kinase in a chronic depression model

Ann N Y Acad Sci. 2008 Dec:1148:509-14. doi: 10.1196/annals.1410.076.

Abstract

Neurotransmitter- or neurotrophin-regulated intracellular signaling in the hippocampus is hypothesized to contribute to depression and antidepressant (ADT) efficacy. Extracellular signal-regulated kinase 1/2 (ERK1/2) is downstream of several receptor types and regulates transcriptional activity of many targets; ERK1/2 may thereby influence mood and affect. Using a novel, ADT-sensitive depression model in mice, we show that prior corticosterone exposure decreases motivated behavior, sucrose consumption, and pERK1/2 in the dentate gyrus, but not in CA1/CA3. Notably, prefrontal cortical targets were also regulated. Our data suggest ADTs restore hippocampal pERK1/2 after stress-related insult, and potentially reveal a novel role for prefrontal neurotrophins in depressive-like symptomology.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antidepressive Agents / therapeutic use
  • Behavior, Animal / drug effects
  • Behavior, Animal / physiology
  • Brain-Derived Neurotrophic Factor / metabolism
  • Conditioning, Operant
  • Corticosterone / metabolism*
  • Corticosterone / pharmacology
  • Depression / drug therapy
  • Depression / metabolism*
  • Depression / physiopathology
  • Disease Models, Animal*
  • Hippocampus / anatomy & histology
  • Hippocampus / metabolism
  • MAP Kinase Signaling System / physiology
  • Mice
  • Mice, Inbred C57BL
  • Mitogen-Activated Protein Kinase 1 / metabolism*
  • Mitogen-Activated Protein Kinase 3 / metabolism*

Substances

  • Antidepressive Agents
  • Brain-Derived Neurotrophic Factor
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Corticosterone